Skip to main content

Advertisement

Log in

Interleukin-6 receptor expression in the peripheral B cells of patients with multicentric Castleman's disease

  • ORIGINAL ARTICLE
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

 Interleukin-6 (IL-6) is an important regulator of terminal B-cell differentiation. Inappropriate oversynthesis of IL-6 may play a primary role in the pathogenesis of multicentric Castleman's disease (MCD). We investigated the expression of the IL-6 receptor (IL-6R) in peripheral B cells from three patients with MCD, as well as the responsiveness of these cells to IL-6. Flow-cytometric analysis showed that IL-6R was significantly expressed on the peripheral B cells of two of three patients. The B cells expressing IL-6R spontaneously produced increased levels of immunoglobulin G (IgG). IL-6R-expressing B cells from one patient showed hyper-responsiveness to IL-6.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 6 March 1996 / Accepted: 12 June 1996

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ishiyama, T., Koike, M., Nakamura, S. et al. Interleukin-6 receptor expression in the peripheral B cells of patients with multicentric Castleman's disease. Ann Hematol 73, 179–182 (1996). https://doi.org/10.1007/s002770050224

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002770050224

Navigation